NCT01580124View on ClinicalTrials.gov

CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2015

Conditions
Atrial FibrillationPersistent Atrial Fibrillation
Interventions
PROCEDURE

PVI alone

PVI alone Pulmonary vein isolation alone in persistent atrial fibrillation

PROCEDURE

PVI + Defragmentation + linear lesions

PVI + Defragmentation + linear lesions AF ablation continuation aiming for AF termination

Trial Locations (1)

20251

University Hospital Eppendorf, Hamburg

Sponsors

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER